(redirected from respiratory syncytial virus)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
See: disease
References in periodicals archive ?
Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides.
These abstracts advance the body of existing data and knowledge surrounding influenza and respiratory syncytial virus (RSV) prevention, highlighting MedImmune's continued leadership in patient health.
Respiratory syncytial virus infection in children hospitalised with acute lower respiratory tract infection.
Top 5 Companies in Marketed Respiratory Syncytial Virus (RSV) Infection Products
Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein.
The PREVENT (Prophylaxis of Respiratory Syncytial Virus in Elevated- risk Neonates) trial, is a randomized, double blind, placebo controlled, Phase 3 trial.
Human metapneumovirus in severe respiratory syncytial virus bronchiolitis.
Respiratory Syncytial Virus (RSV) is the leading cause of viral pneumonia and bronchiolitis in children and is recognized as one of the most serious illnesses of early childhood.
Now available for routine hospital and clinical laboratory use are direct fluorescence tests for influenza type A, influenza type B, respiratory syncytial virus (RSV) and an indirect fluorescence test for cytomegalovirus early antigen (CMV-EA).
completed manufacturing of a clinical infectious inoculum of respiratory syncytial virus (RSV) in its biopharmaceutical facility located in Memphis, TN.
2% of patients with influenzalike illness who had tested negative for influenza virus and human respiratory syncytial virus (HRSV).

Full browser ?